Senti BiosciencesSNTI
13F holders, Q3 2024 (September 30)12holders
1famous investor
$2.26avg. 13F price*
At the end of Q3 2024, 12 institutions reported holding Senti Biosciences Inc. (SNTI) in their 13F filings. The largest holders were NEA Management Company, LLC ($1.0M), ARK Investment Management ($399K) and Vanguard Group Inc. ($220K). One famous investor held it Cathie Wood (0.0% of ARK Investment Management's portfolio).
- Company
- Senti Biosciences Inc.
- CUSIP
- 81726A209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 12 | $1.7M |
| Exits | 0 | $0 |
Ownership 12 holders
| NEA Management Company, LLC | 0.05% | New | 442,615 | $1.0M |
| ARK Investment Management | 0.00% | New | 176,666 | $399K |
| Vanguard Group Inc. | 0.00% | New | 97,467 | $220K |
| Geode Capital Management, LLC | 0.00% | New | 27,293 | $62K |
| UBS Group AG | 0.00% | New | 10,497 | $24K |
| BlackRock, Inc. | 0.00% | — | 4,004 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 2,359 | $5K |
| Harbour Investments, Inc. | 0.00% | New | 1,500 | $3K |
| Morgan Stanley | 0.00% | New | 566 | $1K |
| Barclays PLC | 0.00% | New | 500 | $1K |
| Bank of America Corp. | 0.00% | New | 351 | $793 |
| Citigroup Inc. | 0.00% | New | 166 | $375 |
"% of holder's portfolio" is SNTI's weight in each manager's 13F, not the share of Senti Biosciences Inc. the manager owns.